Fanny Tomas

Title: Fanny Tomas: Innovator in Cancer Stem Cell Research

Introduction

Fanny Tomas is a prominent inventor based in Montpellier, France. She has made significant contributions to the field of oncology, particularly in the study of cancer stem cells. Her innovative work has led to the development of a patent that addresses critical aspects of cancer treatment and research.

Latest Patents

Fanny Tomas holds a patent for her invention titled "Delta133P53Beta and Delta133P53Gamma isoforms are biomarkers of cancer stem cells." This invention focuses on a method for producing cancer stem cells through the overexpression of Δ133p53β and Δ133p53γ isoforms. It also includes a method for predicting the risk that treatment with chemotherapeutic agents may induce cancer stem cells in patients. The patent outlines therapeutic uses of a combination of chemotherapeutic agents and agents that reduce the expression of these isoforms, as well as screening methods for anti-cancer stem cell agents. She has 1 patent to her name.

Career Highlights

Throughout her career, Fanny Tomas has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Montpellier. Her research has been pivotal in advancing the understanding of cancer stem cells and their implications in cancer treatment.

Collaborations

Fanny has collaborated with notable colleagues, including Pierre Roux and Nikola Arsic. These partnerships have enriched her research and contributed to the development of innovative solutions in oncology.

Conclusion

Fanny Tomas is a trailblazer in cancer stem cell research, with a focus on developing methods that could revolutionize cancer treatment. Her contributions are vital to the ongoing fight against cancer, and her work continues to inspire future innovations in the field.